Cargando…

365. Candida Bloodstream Infections in a Tertiary Care Hospital in Costa Rica, 5-Year Experience

BACKGROUND: Invasive fungal bloodstream infections (BSI) display high morbidity and mortality. Epidemiologic data from Central America, including geographic distribution and mortality is scarce. METHODS: Patients of all age groups with a positive Candida spp. blood culture from January 2012 to Decem...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Sanchez, Mariana, Chaverri-Murillo, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255579/
http://dx.doi.org/10.1093/ofid/ofy210.376
_version_ 1783373974588096512
author Garcia-Sanchez, Mariana
Chaverri-Murillo, Jorge
author_facet Garcia-Sanchez, Mariana
Chaverri-Murillo, Jorge
author_sort Garcia-Sanchez, Mariana
collection PubMed
description BACKGROUND: Invasive fungal bloodstream infections (BSI) display high morbidity and mortality. Epidemiologic data from Central America, including geographic distribution and mortality is scarce. METHODS: Patients of all age groups with a positive Candida spp. blood culture from January 2012 to December 2017. Only initial episodes was accounted per patient. Demographic data was retrospectively collected and analyzed. Between-group differences were compared using Chi2, logistic regression used to calculate odds ratios, and survival analysis using Kaplan Meier. RESULTS: 243 episodes of Candida spp. BSI occurred during the study period, increasing over time. A median 21 days of hospital stay to the first episode of candidemia (IQR 14–32). Candida albicans represented 51% of episodes, followed by C. parapsilosis 27%, C. glabrata 9%, C. tropicalis 9%, C. haemulonii 1.6%, C. krusei, C. pelliculosa, C. guilllermondi. Male sex predominated (62%) over females (38%), median age was 54 years. Age group distribution corresponded to 23 newborns (9%), 6 adolescents (3%), 141 adults (58%), and 72 elders (30%). Surgical wards and surgical ICU comprised for 47% of cases. Admission for intraabdominal pathology; 35% of cases, followed by cancer 21% (63% solid tumors, 37% hematologic malignancies), 11% trauma and orthopedic surgery. Overall resistance rates were 14% fluconazole, 5% voriconazole and 8% for amphotericin B, no resistance to echinocandins detected. Overall mortality was 69%. Mortality by species C. krusei 100%, C. tropical 95%, C. glabrata 81%, C. albicans 68%, C. parapsilosis 59%, C. haemulonii 50%, (P = 0.02). No fatalities occurred with C. pelliculosa and C. guillermondi. Mortality was highest in elderly (69%), followed by adults (65%) and adolescents (50%) (P = 0.039). Death OR was 2.13 for elders vs. the adult group (P = 0.02, CI 1.097–4.155). A negative correlation was documented between age group and survival (rho -0.3250 P < 0.00001). CONCLUSION: Candida BSI show an increasing trend over time in our cohort. Candida parapsilosisis as the second cause of candidemia displays lower mortality than its counterparts. Mortality was higher than previously reported and is highest in the elderly. Antimicrobial stewardship programs, source control in abdominal surgeries and appropriate central venous catheter use need to be implemented to improve outcomes. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6255579
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62555792018-11-28 365. Candida Bloodstream Infections in a Tertiary Care Hospital in Costa Rica, 5-Year Experience Garcia-Sanchez, Mariana Chaverri-Murillo, Jorge Open Forum Infect Dis Abstracts BACKGROUND: Invasive fungal bloodstream infections (BSI) display high morbidity and mortality. Epidemiologic data from Central America, including geographic distribution and mortality is scarce. METHODS: Patients of all age groups with a positive Candida spp. blood culture from January 2012 to December 2017. Only initial episodes was accounted per patient. Demographic data was retrospectively collected and analyzed. Between-group differences were compared using Chi2, logistic regression used to calculate odds ratios, and survival analysis using Kaplan Meier. RESULTS: 243 episodes of Candida spp. BSI occurred during the study period, increasing over time. A median 21 days of hospital stay to the first episode of candidemia (IQR 14–32). Candida albicans represented 51% of episodes, followed by C. parapsilosis 27%, C. glabrata 9%, C. tropicalis 9%, C. haemulonii 1.6%, C. krusei, C. pelliculosa, C. guilllermondi. Male sex predominated (62%) over females (38%), median age was 54 years. Age group distribution corresponded to 23 newborns (9%), 6 adolescents (3%), 141 adults (58%), and 72 elders (30%). Surgical wards and surgical ICU comprised for 47% of cases. Admission for intraabdominal pathology; 35% of cases, followed by cancer 21% (63% solid tumors, 37% hematologic malignancies), 11% trauma and orthopedic surgery. Overall resistance rates were 14% fluconazole, 5% voriconazole and 8% for amphotericin B, no resistance to echinocandins detected. Overall mortality was 69%. Mortality by species C. krusei 100%, C. tropical 95%, C. glabrata 81%, C. albicans 68%, C. parapsilosis 59%, C. haemulonii 50%, (P = 0.02). No fatalities occurred with C. pelliculosa and C. guillermondi. Mortality was highest in elderly (69%), followed by adults (65%) and adolescents (50%) (P = 0.039). Death OR was 2.13 for elders vs. the adult group (P = 0.02, CI 1.097–4.155). A negative correlation was documented between age group and survival (rho -0.3250 P < 0.00001). CONCLUSION: Candida BSI show an increasing trend over time in our cohort. Candida parapsilosisis as the second cause of candidemia displays lower mortality than its counterparts. Mortality was higher than previously reported and is highest in the elderly. Antimicrobial stewardship programs, source control in abdominal surgeries and appropriate central venous catheter use need to be implemented to improve outcomes. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6255579/ http://dx.doi.org/10.1093/ofid/ofy210.376 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Garcia-Sanchez, Mariana
Chaverri-Murillo, Jorge
365. Candida Bloodstream Infections in a Tertiary Care Hospital in Costa Rica, 5-Year Experience
title 365. Candida Bloodstream Infections in a Tertiary Care Hospital in Costa Rica, 5-Year Experience
title_full 365. Candida Bloodstream Infections in a Tertiary Care Hospital in Costa Rica, 5-Year Experience
title_fullStr 365. Candida Bloodstream Infections in a Tertiary Care Hospital in Costa Rica, 5-Year Experience
title_full_unstemmed 365. Candida Bloodstream Infections in a Tertiary Care Hospital in Costa Rica, 5-Year Experience
title_short 365. Candida Bloodstream Infections in a Tertiary Care Hospital in Costa Rica, 5-Year Experience
title_sort 365. candida bloodstream infections in a tertiary care hospital in costa rica, 5-year experience
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255579/
http://dx.doi.org/10.1093/ofid/ofy210.376
work_keys_str_mv AT garciasanchezmariana 365candidabloodstreaminfectionsinatertiarycarehospitalincostarica5yearexperience
AT chaverrimurillojorge 365candidabloodstreaminfectionsinatertiarycarehospitalincostarica5yearexperience